Cargando…
Atypical myeloproliferative neoplasm with concurrent BCR-ABL1 fusion and CALR mutation: A case report and literature review
RATIONALE: Concurrent calreticulin (CALR) mutation and BCR-ABL1 fusion are extremely rare in chronic myelogenous leukemia; to date, only 12 cases have been reported. PATIENT CONCERNS: A 57-year-old male who had an 11-year history of essential thrombocytosis presented to our hospital with leukocytosi...
Autores principales: | Liu, Chunshui, Hu, Ruiping, Du, Zhonghua, Abecasis, Manuel, Wang, Cong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004640/ https://www.ncbi.nlm.nih.gov/pubmed/32000382 http://dx.doi.org/10.1097/MD.0000000000018811 |
Ejemplares similares
-
Concurrent chronic myeloid leukemia and CALR-mutated myeloproliferative neoplasm
por: Langabeer, Stephen E.
Publicado: (2020) -
Insights from a rare myeloproliferative neoplasm with coexisting
BCR‐ABL1
fusion gene,
CALR,
and
TET2
mutations treated with nilotinib and ruxolitinib
por: Huo, Li, et al.
Publicado: (2023) -
CALR mutation characterization in myeloproliferative neoplasms
por: Bilbao-Sieyro, Cristina, et al.
Publicado: (2016) -
JAK2, CALR, and MPL Mutation Profiles in BCR-ABL Negative Myeloproliferative Neoplasms, a Referral Center Experience in the Middle East
por: Safavi, Moeinadin, et al.
Publicado: (2021) -
CALR mutations in myeloproliferative neoplasms: An unfolding story
por: Langabeer, Stephen E.
Publicado: (2020)